News
Health Canada approves Iovance’s Amtagvi for the treatment of advanced melanoma: San Carlos, California Wednesday, August 20, 2025, 09:00 Hrs [IST] Iovance Biotherapeutics, Inc.
A new Nature study suggests infections like influenza and COVID-19 can trigger dormant cancer cells to awaken, potentially raising the risk of recurrence and metastasis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback